Home > Financial Ratios > NGL FINECHEM

NGL FINECHEM
EBIT Growth

    Back to All Ratios
NGL FINECHEM is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for NGL FINECHEM
Please provide your vote to see the results

NGL FINECHEM Last 5 Year EBIT Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EBIT Growth(%) -44.9292.58-57.38-14.14442.89

What is the latest EBIT Growth ratio of NGL FINECHEM ?

The latest EBIT Growth ratio of NGL FINECHEM is -44.92 based on Mar2025 Consolidated results.
Year EBIT Growth
Mar2025-44.92
Mar202492.58
Mar2023-57.38
Mar2022-14.14
Mar2021442.89

How is EBIT Growth of NGL FINECHEM Trending?

Years EBIT Growth % Change
Mar2025 -44.92
Negative
Mar2024 92.58
Positive
Mar2023 -57.38
Negative
Mar2022 -14.14
Negative
Mar2021 442.89 -

Other Financial Ratios of NGL FINECHEM


Compare EBIT Growth ratio of peers of NGL FINECHEM

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NGL FINECHEM ₹956.0 Cr 0.4% 11.2% -26% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹398,218.0 Cr 0.6% 3.6% -12.5% Stock Analytics
DIVIS LABORATORIES ₹175,158.0 Cr 1% 9.4% 8% Stock Analytics
CIPLA ₹126,710.0 Cr 0.9% 1.2% -0.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹119,586.0 Cr 1.7% 1% 1% Stock Analytics
DR REDDYS LABORATORIES ₹103,496.0 Cr -0.5% -4.2% -6.3% Stock Analytics


NGL FINECHEM Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
NGL FINECHEM

0.4%

11.2%

-26%

SENSEX

1.6%

2.1%

2.6%


You may also like the below Video Courses